Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa

<p>Abstract</p> <p>Background</p> <p>Lamivudine <b>(</b>3TC) is a potent inhibitor of both Hepatitis B virus (HBV) and Human Immunodeficiency Virus (HIV) replication and is part of first-line highly active antiretroviral therapy (HAART) in the Gambia. Unfort...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Stewart Balint, Jobarteh Modou L, Sarge-Njie Ramu, Alabi Abraham, de Silva Thushan, Peterson Kevin, Peterson Ingrid, Whittle Hilton, Rowland-Jones Sarah, Jaye Assan, Cotten Matthew, Mendy Maimuna
Format: Article
Sprog:English
Udgivet: BMC 2011-12-01
Serier:BMC Research Notes
Online adgang:http://www.biomedcentral.com/1756-0500/4/561

Internet

http://www.biomedcentral.com/1756-0500/4/561

Lignende værker